---
schema_version: "secwatch.filing_event.v1"
accession: "0000882095-26-000008"
form_type: "8-K"
ticker: "GILD"
cik: "0000882095"
company_name: "GILEAD SCIENCES, INC."
filed_at: "2026-05-04T23:59:59+00:00"
generated_at: "2026-05-15T00:10:55.630983+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Gilead shareholders elect all nine directors, approve equity plan increase, reject three proposals

## Summary
- All nine director nominees elected; Daniel O'Day received 980.6M votes for, 50.2M against.
- Ernst & Young ratified as auditor for FY 2026: 1,046.4M for, 82.8M against, 1.0M abstain.
- Say-on-pay approved with 954.3M for (92.6% of votes cast excluding broker non-votes).
- Amended 2022 Equity Incentive Plan approved, adding 47.75M new shares to the pool.
- Shareholder proposals on independent chair, patent exclusivity, and ESG metrics all defeated by wide margins.

## SEC filing metadata
- accession: 0000882095-26-000008
- form_type: 8-K
- ticker: GILD
- cik: 0000882095
- company_name: GILEAD SCIENCES, INC.
- filed_at: 2026-05-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/882095/000088209526000008/0000882095-26-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/882095/000088209526000008/gild-20260430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000882095-26-000008
- JSON: https://secwatch.observer/filing/0000882095-26-000008.json
- Plain text: https://secwatch.observer/filing/0000882095-26-000008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.